Start 30 days free, no card. Full Pro access for a month, then decide. Start free

Back to analysts list

Analyst

Fulvio Cazzol

Berenberg · covers Basic Materials

Period: Reporting periods mapped to calendar 2025 Q3 – 2026 Q1 (3 quarters).

Limited coverage. Only 3 questions of coverage. Treat these numbers as directional — sample too small for reliable averages.
Questions
3on tracked calls
Challenge rate
0%none of 3 questionsLimited sample
Companies
1questioned at least once
Reporting periods
3with questions

These figures cover the whole profile: every tracked question, all reporting periods.

How to read these numbers

Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.

Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.

No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.

Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.

Small samples. Profiles with fewer than 10 questions are marked Limited sample.

Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.

Questions asked

Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.

Showing 3 of 3 questions from 1 company

IFFInternational Flavors & Fragrances3 questions · 3 reporting periods · 0 of 3 challenging
IFF company page →

Calendar 2026 Q1

for the rest of the segments, is that still your expectation?

Revenue GrowthMacroeconomicTranscript · FY2026 Q1 →
Show response

Erik confirmed sequential acceleration thesis holds outside of Middle East impact. Q1 beat expectations, Q2 challenged by Fine Fragrance/Middle East and cost inflation, but H2 commercial pipelines expected to deliver, supporting full-year confidence.

Calendar 2025 Q4

I was just wondering if you can give us a bit of a summary of what you expect both on the input costs, any tariff-related cost inflation, wage inflation and how you expect to mitigate that

Cost PressureTrade TariffsTranscript · FY2025 Q4 →
Show response

DeVeau expects modest broad-based input cost inflation in 2026 including tariff impact. Top line growth entirely volume-driven with pricing slightly down from Fragrance Ingredients commodity and Food Ingredients carryover. Wage inflation fully offset by gross productivity plan.

Calendar 2025 Q3

I was wondering if you can provide a bit more color on what's exactly going on in the North America region for the Health business unit

DemandCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

Erik confirmed North America Health has been slow, with new leadership and increased R&D investment since H2 2024. Expects improvements in H2 2026, full recovery in 2027.

Challenge rate by company

Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.

CompanyQuestionsChallenge rate
IFF International Flavors & Fragrances30%none of 3 questions
  • IFF
    International Flavors & Fragrances · 3 questions
    0%none of 3 questions

Activity by reporting period

Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.

Questions by calendar reporting period
Calendar periodQuestionsChallenge rateCompanies
2025 Q310%none of 1 question1
2025 Q410%none of 1 question1
2026 Q110%none of 1 question1
  1. 2025 Q31 question · challenge rate 0% (none of 1 question) · 1 company
  2. 2025 Q41 question · challenge rate 0% (none of 1 question) · 1 company
  3. 2026 Q11 question · challenge rate 0% (none of 1 question) · 1 company

Topics

Topics tagged on this analyst’s questions.

  • Revenue Growth1
  • Macroeconomic1
  • Cost Pressure1
  • Trade Tariffs1
  • Demand1
  • Competitive Dynamics1